FGF2 and neoplasm: During numerous investigations regarding tumor progression, expression levels of pro-angiogenic regulators, such as vascular endothelial growth factor-A (VEGF-A), basic fibroblast growth factor (bFGF), and angiopoietin 1 and 2 (Ang1, Ang2), are usually increased.